We will screen your medical history and determine if you are a candidate for our weight loss program, which includes GLP-1 medications if applicable
are eligible for semaglutide, primarily for weight loss, diabetes management, or cardiovascular prevention
In the ATTAIN-1 trial, participants on the highest dose lost an average of 27.3 pounds (12.4% of body weight) compared to 2.2 pounds for the placebo group
DEXA scans have shown that individuals on this type of medication lose muscle and bone in an accelerated way if they do not incorporate exercise, leading them to suffer long-term consequences
Whether youre someone considering these medications for your own health or a fitness professional trying to better understand how they fit into the broader health landscape, this episode will offer valuable insights on what you dont know about GPL-1
The intake is of average length, the consultation is asynchronous (no video call scheduling), and your prescription could be approved as soon as the next day